Skip to main content

SPHERA FUNDS MANAGEMENT LTD.

Position in ELDN — Eledon Pharmaceuticals, Inc.

CIK 1496201 TEL AVIV, L3

Position in ELDN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,693,276
-$764,887 QoQ
Shares Held
1,191,187
-32.8% QoQ
Ownership
1.47%
of shares outstanding
% of Portfolio
0.68%
of 13F equity value
Holder Rank
#11
of 159 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ELDN Over Time

Shares Held

Position Value (USD)

Derivatives in ELDN

reported options exposure · as of Sep 30, 2025
CallValue
$0
CallShares
0
PutValue
$518,000
PutShares
200,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SPHERA FUNDS MANAGEMENT LTD. holds $446,413,848 across 71 Biotechnology names. ELDN ranks #32 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ELDN

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,693,276 1,191,187
2026-03-31 $5,458,163 1,772,131
2025-12-31 $3,219,517 2,132,131
2025-09-30 $518,000 200,000
2025-09-30 $3,315,803 1,280,233
2025-06-30 $5,310,543 1,959,610
2025-06-30 $84,552 31,200
2025-03-31 $7,821,133 2,307,119
2024-12-31 $10,512,670 2,551,619
2024-09-30 $3,230,329 1,297,321
2024-06-30 $3,424,135 1,297,021